Is Stoke Therapeutics, Inc. (STOK) a Buy, Sell, or Hold?
NASDAQ : STOK
Stoke Therapeutics, Inc. — Institutional Ownership
$29.39 USD
$0.08 (0.27%)
- Volume
- 582.91K
- Average Volume
- 720.36K
- Market Capitalization
- $1.83B
- P/E Ratio
- -10.39
- Dividend Yield
- 0.00%
- Price Target
- $44.00
- Year High
- $40.22
- Year Low
- $12.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.99
Institutional Ownership Summary
Institutional Ownership %
2.62%
Investors Holding
23
change: -181 | last: 204
Increased Positions
9
change: -112 | last: 121
Reduced Positions
7
change: -46 | last: 53
New Positions
3
change: -37 | last: 40
Sold Positions
176
change: 146 | last: 30
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -245.3959 | last: 2.454
Total Invested
53.98M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-18 | Lynx1 Capital Management LP | 4.76M | 8.10% |
| 2026-05-15 | Redmile Group, LLC | 4.16M | 6.70% |
| 2026-05-15 | The Toronto-Dominion Bank | 3.17M | 5.40% |
| 2026-05-15 | RTW Investments, LP | 5.94M | 9.90% |
| 2026-05-15 | Wellington Management Group LLP | 3.1M | 5.20% |
| 2026-05-15 | Lynx1 Capital Management LP | 4.12M | 7.00% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Baker Bros. Advisors LP | 3.34M | 5.80% |
| 2026-02-05 | FMR LLC | 5.6M | 9.80% |
| 2025-11-14 | The Toronto-Dominion Bank | 3.17M | 5.80% |
| 2025-11-14 | Cowen Financial Products LLC | - | 0.00% |
| 2025-11-05 | FMR LLC | 6.87M | 12.50% |
| 2025-10-17 | BlackRock, Inc. | 3.73M | 6.80% |
| 2025-08-26 | Ezbon International Ltd | 288.56K | 0.50% |
| 2025-08-26 | Skorpios Trust | 2.26M | 4.10% |
| 2025-08-26 | Montrago Trustees Ltd | 2.26M | 4.10% |
| 2025-08-26 | Blue Horizon Enterprise Ltd | 1.97M | 3.60% |
| 2025-08-14 | Redmile Group, LLC | 4.38M | 8.00% |
| 2025-08-06 | FMR LLC | 7.41M | 13.60% |
| 2025-07-29 | Cowen Financial Products LLC | 3.17M | 5.80% |
| 2025-07-15 | BlackRock Portfolio Management LLC | 2.55M | 4.70% |
| 2025-06-23 | Montrago Trustees Ltd | 3.26M | 6.00% |
| 2025-06-23 | Blue Horizon Enterprise Ltd | 2.97M | 5.40% |
| 2025-06-23 | Ezbon International Ltd | 288.56K | 0.50% |
| 2025-06-23 | Skorpios Trust | 3.26M | 6.00% |
| 2025-06-06 | Blue Horizon Enterprise Ltd | 2.97M | 5.40% |
| 2025-06-06 | FMR LLC | 5.86M | 10.70% |
| 2025-06-06 | Skorpios Trust | 3.91M | 7.20% |
| 2025-06-06 | Montrago Trustees Ltd | 3.91M | 7.20% |
| 2025-06-06 | Ezbon International Ltd | 938.56K | 1.70% |
| 2025-04-16 | BlackRock, Inc. | 3.12M | 5.80% |
| 2025-04-15 | BlackRock Portfolio Management LLC | 2.74M | 5.10% |
| 2025-02-14 | RTW Investments, LP | 5.31M | 9.99% |
| 2025-02-03 | Morgan Stanley | 3.43M | 6.50% |
| 2024-11-14 | Baker Bros. Advisors (GP) LLC | 4.37M | 8.30% |
| 2024-11-14 | Felix J. Baker | 4.37M | 8.30% |
| 2024-11-14 | Baker Bros. Advisors (GP) LLC | 4.37M | 8.30% |
| 2024-11-14 | Julian C. Baker | 4.37M | 8.30% |
| 2024-11-14 | Felix J. Baker | 4.37M | 8.30% |
| 2024-11-14 | Baker Bros. Advisors LP | 4.37M | 8.30% |
| 2024-11-14 | Baker Bros. Advisors LP | 4.37M | 8.30% |
| 2024-11-14 | Julian C. Baker | 4.37M | 8.30% |
| 2024-02-26 | 27-0423711 | 2.28M | 5.77% |
| 2023-11-06 | Weston Nichols | 2.66M | 6.00% |
| 2023-11-06 | Lynx1 Capital Management LP | 2.66M | 6.00% |
| 2023-11-06 | Weston Nichols | 2.66M | 6.00% |
| 2023-11-06 | Lynx1 Capital Management LP | 2.66M | 6.00% |
| 2023-02-10 | Morgan Stanley Capital Services LLC | 2.43M | 6.20% |
| 2023-02-10 | Morgan Stanley | 2.45M | 6.20% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 1.91M | 5.20% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 1.91M | 5.20% |
| 2021-06-30 | Montrago Trustees Limited | 14.44M | 39.30% |
| 2021-06-30 | Blue Horizon Enterprise Ltd. | 6.91M | 18.80% |
| 2021-06-30 | Skorpios Trust | 14.44M | 39.30% |
| 2021-06-30 | Blue Horizon Enterprise Ltd. | 6.91M | 18.80% |
| 2021-06-30 | Montrago Trustees Limited | 14.44M | 39.30% |
| 2021-06-30 | Ezbon International Limited | 7.54M | 20.50% |
| 2021-06-30 | Ezbon International Limited | 7.54M | 20.50% |
| 2021-06-30 | Skorpios Trust | 14.44M | 39.30% |
| 2021-02-16 | Redmile Group, LLC | 2.69M | 7.40% |
| 2021-02-16 | Redmile Group, LLC | 2.69M | 7.40% |
| 2021-02-16 | Jeremy C. Green | 2.69M | 7.40% |
| 2021-02-16 | Cormorant Private Healthcare Fund II, LP | 538.81K | 1.49% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | 434.47K | 1.20% |
| 2021-02-16 | Cormorant Private Healthcare GP II, LLC | 538.81K | 1.49% |
| 2021-02-16 | Jeremy C. Green | 2.69M | 7.40% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | 434.47K | 1.20% |
| 2021-02-16 | Gilder, Gagnon, Howe & Co. LLC | 1.47M | 4.06% |
| 2021-02-16 | Cormorant Global Healthcare GP, LLC | 434.47K | 1.20% |
| 2021-02-16 | Cormorant Private Healthcare GP, LLC | 448.99K | 1.24% |
| 2021-02-16 | Bihua Chen | 1.44M | 3.97% |
| 2021-02-16 | Gilder, Gagnon, Howe & Co. LLC | 1.47M | 4.06% |
| 2021-02-16 | Cormorant Private Healthcare Fund I, LP | 448.99K | 1.24% |
| 2021-02-16 | Cormorant Asset Management, LP | 1.44M | 3.97% |
| 2021-02-08 | Abigail P. Johnson | 3.6M | 9.94% |
| 2021-02-08 | FMR LLC | 3.6M | 9.94% |
| 2021-02-08 | FMR LLC | 3.6M | 9.94% |
| 2021-02-08 | Abigail P. Johnson | 3.6M | 9.94% |
| 2020-02-14 | Cormorant Asset Management, LP | 1.79M | 5.46% |
| 2020-02-14 | Cormorant Private Healthcare GP II, LLC | 538.81K | 1.65% |
| 2020-02-14 | Cormorant Private Healthcare Fund II, LP | 538.81K | 1.65% |
| 2020-02-14 | Bihua Chen | 1.79M | 5.46% |
| 2020-02-14 | Cormorant Global Healthcare Master Fund, LP | 741.88K | 2.27% |
| 2020-02-14 | Cormorant Private Healthcare GP, LLC | 448.99K | 1.37% |
| 2020-02-14 | Cormorant Private Healthcare Fund I, LP | 448.99K | 1.37% |
| 2020-02-14 | Cormorant Global Healthcare GP, LLC | 741.88K | 2.27% |
| 2020-02-14 | LLC | 1.83M | 5.58% |
| 2020-02-14 | LLC | 1.83M | 5.58% |
| 2020-02-14 | Cormorant Global Healthcare Master Fund, LP | 741.88K | 2.27% |
| 2020-02-14 | Bihua Chen | 1.79M | 5.46% |
| 2020-02-14 | Cormorant Asset Management, LP | 1.79M | 5.46% |
| 2020-02-14 | Cormorant Private Healthcare GP II, LLC | 538.81K | 1.65% |
| 2020-02-14 | Cormorant Private Healthcare Fund II, LP | 538.81K | 1.65% |
| 2020-02-14 | Cormorant Private Healthcare GP, LLC | 448.99K | 1.37% |
| 2020-02-14 | Cormorant Private Healthcare Fund I, LP | 448.99K | 1.37% |
| 2020-02-14 | Cormorant Global Healthcare GP, LLC | 741.88K | 2.27% |
| 2019-07-01 | Cormorant Private Healthcare Fund II, LP | 538.68K | 1.65% |
| 2019-07-01 | Bihua Chen | 1.87M | 5.73% |
| 2019-07-01 | Cormorant Private Healthcare Fund I, LP | 448.88K | 1.38% |
| 2019-07-01 | Cormorant Asset Management, LP | 1.87M | 5.73% |
| 2019-07-01 | Cormorant Private Healthcare GP II, LLC | 538.68K | 1.65% |
| 2019-07-01 | Bihua Chen | 1.87M | 5.73% |
| 2019-07-01 | Cormorant Private Healthcare Fund I, LP | 448.88K | 1.38% |
| 2019-07-01 | Cormorant Global Healthcare GP, LLC | 801.17K | 2.45% |
| 2019-07-01 | Cormorant Global Healthcare Master Fund, LP | 801.17K | 2.45% |
| 2019-07-01 | Cormorant Private Healthcare GP, LLC | 448.88K | 1.38% |
| 2019-07-01 | Cormorant Private Healthcare Fund II, LP | 538.68K | 1.65% |
| 2019-07-01 | Cormorant Asset Management, LP | 1.87M | 5.73% |
| 2019-07-01 | Cormorant Global Healthcare Master Fund, LP | 801.17K | 2.45% |
| 2019-07-01 | Cormorant Global Healthcare GP, LLC | 801.17K | 2.45% |
| 2019-07-01 | Cormorant Private Healthcare GP, LLC | 448.88K | 1.38% |
| 2019-07-01 | Cormorant Private Healthcare GP II, LLC | 538.68K | 1.65% |
| 2019-06-28 | RTW Investments, LP | 3.36M | 10.67% |
| 2019-06-28 | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | 3.36M | 10.67% |
| 2019-06-28 | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | 3.36M | 10.67% |
| 2019-06-28 | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | 2.57M | 8.17% |
STOK Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $31.74 | 59.22M | $1.88B | $84.22M | $3.01M | $1.8B |
| 2024-12-31 | $11.03 | 54.01M | $595.72M | $127.98M | $4.77M | $472.51M |
| 2023-12-31 | $5.26 | 43.99M | $231.41M | $191.44M | $2.06M | $42.03M |
| 2022-12-31 | $9.23 | 38.9M | $359.02M | $113.56M | $2.36M | $247.83M |
| 2021-12-31 | $23.99 | 36.74M | $881.38M | $144.9M | $5.04M | $741.52M |
| 2020-12-31 | $61.93 | 33.49M | $2.07B | $287.31M | $1.07M | $1.79B |
| 2019-12-31 | $28.32 | 17.97M | $508.95M | $222.47M | -$ | $286.48M |
| 2018-12-31 | $25.57 | 23.51M | $601.2M | $105.4M | -$ | $495.8M |
| 2017-12-31 | $25.57 | 23.51M | $601.2M | $1.8M | $3M | $602.4M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32.56 | 63.06M | $2.05B | $155.66M | $3.42M | $1.9B |
| 2025-12-31 | $31.74 | 58.39M | $1.85B | $84.22M | $3.01M | $1.77B |
| 2025-09-30 | $23.50 | 58.61M | $1.38B | $83.39M | $2.91M | $1.3B |
| 2025-06-30 | $11.35 | 58.35M | $662.32M | $101.47M | $2.3M | $563.14M |
| 2025-03-31 | $6.65 | 57.86M | $384.79M | $274.82M | $2.35M | $112.32M |
| 2024-12-31 | $11.03 | 57.03M | $629.03M | $127.98M | $4.77M | $505.82M |
| 2024-09-30 | $12.29 | 56.34M | $692.43M | $150.02M | $2.3M | $544.71M |
| 2024-06-30 | $13.87 | 55.77M | $773.47M | $193.48M | $2.28M | $582.27M |
| 2024-03-31 | $13.49 | 46.25M | $623.87M | $178.58M | $2.21M | $447.5M |
| 2023-12-31 | $5.26 | 44.96M | $236.48M | $191.44M | $2.06M | $47.1M |
| 2023-09-30 | $3.94 | 44.27M | $174.41M | $189.98M | $2.5M | -$13.07M |
| 2023-06-30 | $10.63 | 44.19M | $469.72M | $192.06M | $2.45M | $280.11M |